Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-62.91	17.36	46.82
Graham Fair Price	79.50	6.24	3.48
PEG	-90.73	0.06	-0.61
Price/Book	4.93	1.27	1.21
Price/Cash Flow	48.74	-9.91	-19.34
Prices/Earnings	-66.91	12.40	37.46
Price/Sales	-47.44	1.32	2.51
Price/FCF	48.74	-9.91	-19.34
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-26.28	0.13	0.18
Operating Margin	0.00	0.03	0.03
ROA	217.43	0.01	< 0.005
ROE	< 0.005	0.03	217.09
ROIC	< 0.005	0.02	187.79
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.07	0.14	-48.15
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.53	1.00	89.90
EPS QOQ	-0.61	2.19	257.09
FCF QOQ	0.52	-1.05	102.57
Revenue QOQ	-0.46	1.00	118.07
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.48	0.23	-52.74
Days Sales Outstanding (DSO)	39.66	24.10	-39.24
Inventory Turnover	187.09	395.90	111.61
Debt/Capitalization	0.33	0.11	-68.42
Quick Ratio	1.18	1.25	6.11
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	8.16	8.23	0.80
Cash	4.37	4.40	0.62
Capex	-1.55	-3.15	-102.92
Free Cash Flow	-0.51	-1.05	-106.35
Revenue	3.93	7.90	101.24
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.32	1.32	0.22
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-1.40	0.02	-98.30
Naive Interpretation	Member

06 - Financial Health · Weak

Rating